Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)

Inclusion Criteria: * Patient has chronic hepatitis C (Genotype 1) * Patient has the ability to avoid use of anticoagulants, nonsteroidal anti-inflammatory drugs and aspirin for at least 5 days before the liver biopsy Exclusion Criteria: * Patient has received any approved or investigational drugs for the treatment of hepatitis C in the six months before the liver biopsy * Patient has HIV or Hepatitis B virus * Patient has been diagnosed with liver cancer * Patient has evidence of cirrhosis on any previous liver biopsy * Patient has confirmed alcohol abuse in the last 12 months * Patient has participated in any investigational drug study within 90 days before the current study